Control System Upgrade from RS3 to DeltaV for Global Biotech Company
This case study is for one of the largest global biotech companies in the world, focused on the development and delivery of transformative therapies. With its main HQ in the US, the customer has been in operation for over 30 years and specialised in the class of rare genetic diseases. They approached Zenith Technologies with a requirement to migrate the existing Rosemount (RS3) control system within its manufacturing plant at Allston, Massachusetts to a more modern and efficient solution.
Zenith Technologies began working with the customer in January 2011 to deliver a full feasibility study, execution plan and schedule, detailed scope of work and cost estimate for migration of the control system. This enabled them to plan the project fully and ensure the foundations were sound an solid before going live. It also helped to ensure that everyone knew what the expected outcome would be and how they were going to reach it.
At a Glance:
Company: Top 10 Global BioTech Company
Project Mission: Control system upgrade from RS3 to DeltaV
Product / Services: Consultancy, Enterprise Integration, Commissioning & Qualification